608
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for 608, covering 2024-10-23 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) [Phase 3]